BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 30, 2026
See today's BioWorld Asia
Home
» Other news to note for Aug. 4, 2020
To read the full story,
subscribe
or
sign in
.
Other news to note for Aug. 4, 2020
Aug. 4, 2020
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Acerus, Affinity, Agenus, Altum, Appili, Avacta, Bergenbio, Betta, Betterlife, Bolt, Celonic, Daewoong, Daiichi Sankyo, Eli Lilly, FSD, G1, Gen1e, Gilead, Grifols, Hansoh, Heat, Humanigen, Hutchison China, Iacta, Immunitybio, Immunome, Immunoprecise Antibodies, Inovio, Intravacc, Johnson & Johnson, Kyorin, Nascent, Neurorx, Neutrolis, Nichi-Iko, Osmotica, Otonomy, Pharmabcine, Piramal Enterprise, Promedica, Qilu, Redhill, Relief, Restorbio, Santen, Schrödinger, Sesen, Simcere, Soligenix, Stemedica Cell, Takeda, Terns, Teva, Theragen, Tscan, Viva, Wuxi Shuangliang.
BioWorld Asia
Briefs
Other news to note